TrialEuropean journal of clinical pharmacology2026

Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial.

Nourhan Osama Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.